In this week’s InnovationRx newsletter, the worsening measles outbreak, a noninvasive brain-computer implant, replacing heart ...

Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...

Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...

Singer Roberta Flack dies, 88. Harlem's Abyssinian Church memorializes her March 10th with a public 'Celebration of Life.' ...

A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and phosphorylated tau 181.

That means he works with media members like myself to help us cover the event. For two weeks every year, our worlds collide. ...

Motor neuron diseases are a group of fatal progressive disorders that rob the body and brain of the ability to function.

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully help contribute to ending ALS.

Novo Nordisk considers exploring GLP-1 drugs like semaglutide for addiction treatment, following Eli Lilly's interest.

Experts warn that difficulty swallowing, producing excess saliva or even drooling could be a sign of motor neurone disease ...